Desk Report :: Beximco Pharmaceuticals is buying about 3 million doses of corona vaccine from the Serum Institute of India for sale in the Bangladesh market privately outside the government program. They will pay the Serum Institute eight dollars for each dose.
Beximco’s Chief Operating Officer (COO) Rabbur Razer made the remarks in a mobile phone interview with Reuters on Tuesday (January 12th).
He said the activities could start next month. It will cost about one thousand 125 rupees (. 13.28) per dose. Out of 3 million, the contract for 1 million doses has already been completed. Now I am planning to collect another 20 lakh doses.
The COO of Beximco Pharmaceuticals added that Beximco will provide 5 million doses of vaccine per month in the first half of the year for the government’s immunization program. The Serum Institute will start supplying vaccines to the government and for sale in the market later this month. People who want to get vaccinated should take two doses of the vaccine at breaks.
He added that Beximco Pharmaceuticals is the ‘exclusive distributor’ of the vaccine produced by the Serum Institute in Bangladesh as per the agreement signed in August 2020. Apart from this, preliminary discussions have also been held with other Indian vaccine manufacturers such as Biological E and Bharat Biotech. If the government wants, Beximco will also discuss other vaccines.
The Serum Institute is marketing the corona vaccine, invented by Oxford-AstraZeneca, in India. They have also announced to give 30 million doses of this vaccine to Bangladesh. They are taking four dollars from Bangladesh for each dose of corona vaccine. The price is 46 percent higher than the price of the vaccine in India, according to Reuters.
*The article has been translated based on the content of Unitednews24.com by www.unitednews24.com. If there is any problem regarding the content, copyright, please leave a report below the article. We will try to process as quickly as possible to protect the rights of the author. Thank you very much!
*We just want readers to access information more quickly and easily with other multilingual content, instead of information only available in a certain language.
*We always respect the copyright of the content of the author and always include the original link of the source article.If the author disagrees, just leave the report below the article, the article will be edited or deleted at the request of the author. Thanks very much! Best regards!